This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08219/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08219/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://linked.opendata.cz/resource/drugbank/drug/DB08219/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08219/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08219/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08219
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08219 n14:DB08219
dcterms:title
4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE
adms:identifier
n8:10015470 n10:11840966 n11:99444690 n12:DB08219 n13:MTZ
n3:IUPAC-Name
n4:271B42EE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B42F4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B42F3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B42F0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B42F1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B42F2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B42EC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B42ED-363D-11E5-9242-09173F13E4C5 n4:271B42EA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B42EB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B42FA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B42FB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B42F5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B42F6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B42F8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B42F7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B42F9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4300-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4302-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4303-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B42FF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B42FE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4301-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B42EF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B42FC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B42FD-363D-11E5-9242-09173F13E4C5